ACTIVE SESSION TAPE Biotechnology $10M Cap Quant: HOLD

Why Is Matinas BioPharma Holdings, Inc. (MTNB) Stock Down Today?

Updated Nov 19, 2026 6:15 PM ET · Prev Close $0.91

Pro Workspace
Last Session Price
$0.81 -10.98%
-$0.10 vs $0.91 prior close
Intraday Range
$0.81 – $0.90
Open $0.88
Relative Volume
0.38x Avg
19,099 sh
52-Week Range
$0.81 – $3.15
Benchmark Alpha
-9.02% vs SPY
-8.79% vs QQQ
20-Session Trend -52.4%

Session Regime & Catalyst Assessment

68% Signal Conviction
TECHNICAL 68% Driver Weight

Matinas BioPharma Holdings, Inc. Pulling Back 10.98% on 0.38x Relative Volume

Matinas BioPharma Holdings, Inc. (MTNB) is pulling back 10.98% (-$0.10) to $0.81 on 0.38x average session volume. Relative to benchmarks, MTNB is lagging the S&P 500 by -9.02%. 14-day RSI stands at 33.0, keeping momentum in a bearish regime.

NEWS 70% Weight
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Bedminster, N.J., Sept. 04, 2026 Globe Newswire -- Matinas BioPharma Holdings, Inc. the Company NYSE American MTNB announced today that on August 31, 2026, it received a notice the Notice from the NYSE American LLC the N

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($0.81) trades relative to 20-day SMA ($1.26) and 50-day SMA ($1.47).

Volume Confirmation
LOW VOLUME (0.38x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

MTNB lagging the S&P 500 by -9.02%
MTNB Session
-10.98%
$0.81
S&P 500 (SPY)
-1.96%
$715.87
Nasdaq 100 (QQQ)
-2.19%
$645.04
Healthcare (XLV)
-2.05%
$177.46
Alpha vs SPY: -9.02% Alpha vs QQQ: -8.79% Alpha vs XLV: -8.93%

Options Flow & Execution Desk

Recent MTNB Catalyst Headlines

Verified Wire
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals

Will create publicly traded advanced clean energy company focused on modular carbon-free energy, green hydrogen, critical materials and industrial decarbonization Business Combination expected to provide public market pl

Yahoo Finance · Jul 13, 2026

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$0.77
Short-term support band
Upper Bound
$0.85
Short-term resistance band
Key Inflection Level
$0.81 (session support)

Monitor volume expansion above 1.5x RVOL around $0.81 (session support) for directional breakout confirmation.

Technical Regime (MTNB)

BEARISH MA TREND
RSI (14)
33.0
Bearish
20-Day SMA
$1.26
Below 20d
50-Day SMA
$1.47
Below 50d
MACD Signal
Bearish
MACD -0.22
ADX (14)
33.1
Strong trend
10d Momentum
-0.35
Soft 10-day momentum

Retail & Crowd Sentiment

Quiet
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

ICMB, the Twitter handle of a bullish trader, expressed optimism towards $MTNB stock, highlighting its low float, clean balance sheet, positive cash flow, and significant assets. No recent news articles were available.

About Matinas BioPharma Holdings, Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Sector
Healthcare
Market Cap
$10M
Employees
34

Get Instant MTNB Catalyst Alerts

Receive an email alert when MTNB triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

MTNB Session & Catalyst FAQ

Why is MTNB stock down today?

Matinas BioPharma Holdings, Inc. (MTNB) is pulling back 10.98% (-$0.10) to $0.81 on 0.38x average session volume. Relative to benchmarks, MTNB is lagging the S&P 500 by -9.02%. 14-day RSI stands at 33.0, keeping momentum in a bearish regime.

Is MTNB stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 0.38x relative volume (low participation). Our multi-factor model currently rates MTNB as HOLD. Review full valuation, quality, and timing signals on the MTNB Buy or Sell Decision Brief →

What is MTNB's intrinsic value and expected trading range?

At $0.81, MTNB's modeled 1-to-3 session range is $0.77 – $0.85, with a key inflection level at $0.81 (session support). Compare current price against multi-year cash flow projections in the MTNB Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for MTNB?

RSI at 33.0 reflects soft below-midline momentum. MTNB trades at $0.81 relative to its 20-day SMA ($1.26) and 50-day SMA ($1.47), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs